Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ORIFARM GROUP A/S
A/S
Active
Advertising protection
CVR 27347282
Energivej 15, 5260
Odense S
Activities of head offices
· NACE 7010
Est. 2003 · 22 years old
249 employees
Monitor
Share
Denmark
/
Companies
/
Activities of head offices
/
ORIFARM GROUP A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
1M
2M
3M
5M
1M
2021
3M
2022
4M
2023
4M
2024
0M
2025
EBITDA
DKK millions
0M
-9M
-18M
-27M
-36M
-22M
2021
-14M
+36%
2022
-14M
0%
2023
-29M
-107%
2024
-24M
+17%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
1.361
3.437
3.664
3.791
0
Staff expenses
-18.554
-26.034
-26.364
-29.090
-25.421
EBITDA
-22.150
-14.384
-13.528
-28.812
-23.943
Depreciation & amort.
3.664
-5.636
-6.305
-7.828
-6.115
EBIT
-25.814
-20.020
-19.833
-36.640
-30.058
Net financials
46.377
41.016
32.412
33.645
78.399
Profit before tax
20.563
20.996
12.579
-2.995
48.341
Tax
-8.127
-6.408
-9.863
-6.255
-3.420
Net profit
28.690
27.404
22.442
3.260
51.761
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
855.502
1.024.459
1.104.465
1.059.474
995.957
Equity
169.527
188.947
208.098
374.171
413.677
Long-term debt
566.915
583.297
579.812
373.929
347.410
Short-term debt
108.653
241.900
309.963
307.943
231.871
Total debt
675.568
825.197
889.775
681.872
579.281
Financial ratios
5-year trend
EBITDA margin
-2394300000.0%
This company
15.8%
Market median
-15153797568% vs market
2021
2025
Equity ratio
41.5%
This company
38.2%
Market median
+9% vs market
2021
2025
Return on equity
12.5%
This company
18.4%
Market median
+32% vs market
2021
2025
Net profit margin
5176100000.0%
This company
8.1%
Market median
+63902469036% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on ORIFARM GROUP A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
